USPP33391P2 - Cannabis plant named ‘PG 1 19 0125 0002’ - Google Patents
Cannabis plant named ‘PG 1 19 0125 0002’ Download PDFInfo
- Publication number
- USPP33391P2 USPP33391P2 US16/873,352 US202016873352V USPP33391P2 US PP33391 P2 USPP33391 P2 US PP33391P2 US 202016873352 V US202016873352 V US 202016873352V US PP33391 P2 USPP33391 P2 US PP33391P2
- Authority
- US
- United States
- Prior art keywords
- homozygous
- flower
- flowers
- cbg
- cannabis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000218236 Cannabis Species 0.000 title claims abstract 3
- 229930003827 cannabinoid Natural products 0.000 abstract description 19
- 239000003557 cannabinoid Substances 0.000 abstract description 19
- 229940065144 cannabinoids Drugs 0.000 abstract description 11
- 238000000605 extraction Methods 0.000 abstract description 5
- 230000002349 favourable effect Effects 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 229930000044 secondary metabolite Natural products 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 36
- 240000004308 marijuana Species 0.000 description 22
- QXACEHWTBCFNSA-SFQUDFHCSA-N cannabigerol Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-SFQUDFHCSA-N 0.000 description 19
- QXACEHWTBCFNSA-UHFFFAOYSA-N cannabigerol Natural products CCCCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-UHFFFAOYSA-N 0.000 description 18
- 230000012010 growth Effects 0.000 description 14
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 14
- 150000003505 terpenes Chemical class 0.000 description 13
- 235000007586 terpenes Nutrition 0.000 description 12
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 11
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 11
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 10
- 229960004242 dronabinol Drugs 0.000 description 10
- 239000002773 nucleotide Substances 0.000 description 10
- 125000003729 nucleotide group Chemical group 0.000 description 10
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 description 9
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 description 9
- 229950011318 cannabidiol Drugs 0.000 description 9
- 238000010367 cloning Methods 0.000 description 9
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 description 9
- 238000003306 harvesting Methods 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 230000007773 growth pattern Effects 0.000 description 6
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 6
- 210000001672 ovary Anatomy 0.000 description 6
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 5
- 230000001488 breeding effect Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 102000054766 genetic haplotypes Human genes 0.000 description 5
- 230000000762 glandular Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 102000054765 polymorphisms of proteins Human genes 0.000 description 5
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 5
- AAXZFUQLLRMVOG-UHFFFAOYSA-N 2-methyl-2-(4-methylpent-3-enyl)-7-propylchromen-5-ol Chemical compound C1=CC(C)(CCC=C(C)C)OC2=CC(CCC)=CC(O)=C21 AAXZFUQLLRMVOG-UHFFFAOYSA-N 0.000 description 4
- ZLYNXDIDWUWASO-UHFFFAOYSA-N 6,6,9-trimethyl-3-pentyl-8,10-dihydro-7h-benzo[c]chromene-1,9,10-triol Chemical compound CC1(C)OC2=CC(CCCCC)=CC(O)=C2C2=C1CCC(C)(O)C2O ZLYNXDIDWUWASO-UHFFFAOYSA-N 0.000 description 4
- UCONUSSAWGCZMV-HZPDHXFCSA-N Delta(9)-tetrahydrocannabinolic acid Chemical compound C([C@H]1C(C)(C)O2)CC(C)=C[C@H]1C1=C2C=C(CCCCC)C(C(O)=O)=C1O UCONUSSAWGCZMV-HZPDHXFCSA-N 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 230000009417 vegetative reproduction Effects 0.000 description 4
- 238000013466 vegetative reproduction Methods 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 3
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 3
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 3
- WVOLTBSCXRRQFR-DLBZAZTESA-N cannabidiolic acid Chemical compound OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-N 0.000 description 3
- SEEZIOZEUUMJME-FOWTUZBSSA-N cannabigerolic acid Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1C(O)=O SEEZIOZEUUMJME-FOWTUZBSSA-N 0.000 description 3
- SEEZIOZEUUMJME-UHFFFAOYSA-N cannabinerolic acid Natural products CCCCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1C(O)=O SEEZIOZEUUMJME-UHFFFAOYSA-N 0.000 description 3
- SEEZIOZEUUMJME-VBKFSLOCSA-N cannabinerolic acid Chemical compound CCCCCC1=CC(O)=C(C\C=C(\C)CCC=C(C)C)C(O)=C1C(O)=O SEEZIOZEUUMJME-VBKFSLOCSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000012239 gene modification Methods 0.000 description 3
- 230000005017 genetic modification Effects 0.000 description 3
- 235000013617 genetically modified food Nutrition 0.000 description 3
- 229940087305 limonene Drugs 0.000 description 3
- 235000001510 limonene Nutrition 0.000 description 3
- 230000035800 maturation Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000000644 propagated effect Effects 0.000 description 3
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 2
- IQSYWEWTWDEVNO-ZIAGYGMSSA-N (6ar,10ar)-1-hydroxy-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromene-2-carboxylic acid Chemical compound C([C@H]1C(C)(C)O2)CC(C)=C[C@H]1C1=C2C=C(CCC)C(C(O)=O)=C1O IQSYWEWTWDEVNO-ZIAGYGMSSA-N 0.000 description 2
- ZROLHBHDLIHEMS-HUUCEWRRSA-N (6ar,10ar)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCC)=CC(O)=C3[C@@H]21 ZROLHBHDLIHEMS-HUUCEWRRSA-N 0.000 description 2
- IXJXRDCCQRZSDV-GCKMJXCFSA-N (6ar,9r,10as)-6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6h-1,9-epoxybenzo[c]chromene Chemical compound C1C[C@@H](C(O2)(C)C)[C@@H]3C[C@]1(C)OC1=C3C2=CC(CCCCC)=C1 IXJXRDCCQRZSDV-GCKMJXCFSA-N 0.000 description 2
- IAIHUHQCLTYTSF-UHFFFAOYSA-N 2,2,4-trimethylbicyclo[2.2.1]heptan-3-ol Chemical compound C1CC2(C)C(O)C(C)(C)C1C2 IAIHUHQCLTYTSF-UHFFFAOYSA-N 0.000 description 2
- TWKHUZXSTKISQC-UHFFFAOYSA-N 2-(5-methyl-2-prop-1-en-2-ylphenyl)-5-pentylbenzene-1,3-diol Chemical compound OC1=CC(CCCCC)=CC(O)=C1C1=CC(C)=CC=C1C(C)=C TWKHUZXSTKISQC-UHFFFAOYSA-N 0.000 description 2
- YJYIDZLGVYOPGU-XNTDXEJSSA-N 2-[(2e)-3,7-dimethylocta-2,6-dienyl]-5-propylbenzene-1,3-diol Chemical compound CCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 YJYIDZLGVYOPGU-XNTDXEJSSA-N 0.000 description 2
- 108700028369 Alleles Proteins 0.000 description 2
- UVOLYTDXHDXWJU-UHFFFAOYSA-N Cannabichromene Chemical compound C1=CC(C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 UVOLYTDXHDXWJU-UHFFFAOYSA-N 0.000 description 2
- WVOLTBSCXRRQFR-SJORKVTESA-N Cannabidiolic acid Natural products OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-SJORKVTESA-N 0.000 description 2
- REOZWEGFPHTFEI-JKSUJKDBSA-N Cannabidivarin Chemical compound OC1=CC(CCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 REOZWEGFPHTFEI-JKSUJKDBSA-N 0.000 description 2
- KASVLYINZPAMNS-UHFFFAOYSA-N Cannabigerol monomethylether Natural products CCCCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(OC)=C1 KASVLYINZPAMNS-UHFFFAOYSA-N 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- ZROLHBHDLIHEMS-UHFFFAOYSA-N Delta9 tetrahydrocannabivarin Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCC)=CC(O)=C3C21 ZROLHBHDLIHEMS-UHFFFAOYSA-N 0.000 description 2
- 208000010412 Glaucoma Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 230000011681 asexual reproduction Effects 0.000 description 2
- 238000013465 asexual reproduction Methods 0.000 description 2
- YJYIDZLGVYOPGU-UHFFFAOYSA-N cannabigeroldivarin Natural products CCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1 YJYIDZLGVYOPGU-UHFFFAOYSA-N 0.000 description 2
- 235000005607 chanvre indien Nutrition 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 2
- 239000003415 peat Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- GRWFGVWFFZKLTI-UHFFFAOYSA-N α-pinene Chemical compound CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 1
- LHXDLQBQYFFVNW-OIBJUYFYSA-N (-)-Fenchone Chemical compound C1C[C@@]2(C)C(=O)C(C)(C)[C@@H]1C2 LHXDLQBQYFFVNW-OIBJUYFYSA-N 0.000 description 1
- ZYTMANIQRDEHIO-KXUCPTDWSA-N (-)-Isopulegol Natural products C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- 229930006715 (-)-beta-pinene Natural products 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- BZSALXKCVOJCJJ-IPEMHBBOSA-N (4s)-4-[[(2s)-2-acetamido-3-methylbutanoyl]amino]-5-[[(2s)-1-[[(2s)-1-[[(2s,3r)-1-[[(2s)-1-[[(2s)-1-[[2-[[(2s)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy Chemical compound CC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CCCC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](C(N)=O)CC1=CC=CC=C1 BZSALXKCVOJCJJ-IPEMHBBOSA-N 0.000 description 1
- FQTLCLSUCSAZDY-KAMYIIQDSA-N (6Z)-nerolidol Chemical compound CC(C)=CCC\C(C)=C/CCC(C)(O)C=C FQTLCLSUCSAZDY-KAMYIIQDSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- JKMPXGJJRMOELF-UHFFFAOYSA-N 1,3-thiazole-2,4,5-tricarboxylic acid Chemical compound OC(=O)C1=NC(C(O)=O)=C(C(O)=O)S1 JKMPXGJJRMOELF-UHFFFAOYSA-N 0.000 description 1
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- 101000651036 Arabidopsis thaliana Galactolipid galactosyltransferase SFR2, chloroplastic Proteins 0.000 description 1
- 241001465180 Botrytis Species 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- UVOLYTDXHDXWJU-NRFANRHFSA-N Cannabichromene Natural products C1=C[C@](C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 UVOLYTDXHDXWJU-NRFANRHFSA-N 0.000 description 1
- VBGLYOIFKLUMQG-UHFFFAOYSA-N Cannabinol Chemical compound C1=C(C)C=C2C3=C(O)C=C(CCCCC)C=C3OC(C)(C)C2=C1 VBGLYOIFKLUMQG-UHFFFAOYSA-N 0.000 description 1
- 235000008697 Cannabis sativa Nutrition 0.000 description 1
- 101000712615 Cannabis sativa Tetrahydrocannabinolic acid synthase Proteins 0.000 description 1
- ZLHQMHUXJUPEHK-UHFFFAOYSA-N Cannabivarin Natural products CCCc1cc(O)c2c(OC(C)(C)c3ccccc23)c1 ZLHQMHUXJUPEHK-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- XXGMIHXASFDFSM-UHFFFAOYSA-N Delta9-tetrahydrocannabinol Natural products CCCCCc1cc2OC(C)(C)C3CCC(=CC3c2c(O)c1O)C XXGMIHXASFDFSM-UHFFFAOYSA-N 0.000 description 1
- ORKZJYDOERTGKY-UHFFFAOYSA-N Dihydrocannabichromen Natural products C1CC(C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 ORKZJYDOERTGKY-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108700010674 N-acetylVal-Nle(7,8)- allatotropin (5-13) Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- IGHTZQUIFGUJTG-QSMXQIJUSA-N O1C2=CC(CCCCC)=CC(O)=C2[C@H]2C(C)(C)[C@@H]3[C@H]2[C@@]1(C)CC3 Chemical compound O1C2=CC(CCCCC)=CC(O)=C2[C@H]2C(C)(C)[C@@H]3[C@H]2[C@@]1(C)CC3 IGHTZQUIFGUJTG-QSMXQIJUSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000092161 Pithys Species 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 239000000370 acceptor Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- PSVBPLKYDMHILE-UHFFFAOYSA-N alpha-humulene Natural products CC1=C/CC(C)(C)C=CCC=CCC1 PSVBPLKYDMHILE-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 244000213578 camo Species 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- REOZWEGFPHTFEI-UHFFFAOYSA-N cannabidivarine Natural products OC1=CC(CCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 REOZWEGFPHTFEI-UHFFFAOYSA-N 0.000 description 1
- -1 cannabilsoin (CBE) Chemical compound 0.000 description 1
- 229960003453 cannabinol Drugs 0.000 description 1
- SVTKBAIRFMXQQF-UHFFFAOYSA-N cannabivarin Chemical compound C1=C(C)C=C2C3=C(O)C=C(CCC)C=C3OC(C)(C)C2=C1 SVTKBAIRFMXQQF-UHFFFAOYSA-N 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000008124 floral development Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- CJWXCNXHAIFFMH-AVZHFPDBSA-N n-[(2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5r)-2-acetamido-4,5,6-trihydroxy-1-oxohexan-3-yl]oxy-3,5-dihydroxy-6-methyloxan-4-yl]acetamide Chemical compound C[C@H]1O[C@@H](O[C@@H]([C@@H](O)[C@H](O)CO)[C@@H](NC(C)=O)C=O)[C@H](O)[C@@H](NC(C)=O)[C@@H]1O CJWXCNXHAIFFMH-AVZHFPDBSA-N 0.000 description 1
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229910001562 pearlite Inorganic materials 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical class CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 1
- 230000009105 vegetative growth Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Images
Definitions
- Cannabis Hybrid Latin name of the genus claimed: Cannabis Hybrid.
- a novel Cannabis hybrid cultivar, entitled ‘PG 1 19 0125 0002’ is provided.
- ‘PG 1 19 0125 0002’ is the result of a planned breeding program and originated from crosses between privately-owned cultivars. The new cultivar has been vegetatively reproduced by cloning using stem cuttings at Zeiningen, Switzerland. Vegetative clones of ‘PG 1 19 0125 0002’ were tested in controlled indoor growth facilities, greenhouses, and outdoors in open fields. The desired characteristics of each source cultivar are transferred by vegetative, asexual reproduction. ‘PG 1 19 0125 0002’ is stable and consistently true-to-type through multiple generations of vegetative reproduction.
- Cannabis is a genus of flowering plants comprising three historically distinct subspecies based on phenotype and metabolite profiles— Cannabis sativa, Cannabis indica , and Cannabis ruderalis .
- Cannabis sativa a genus of flowering plants comprising three historically distinct subspecies based on phenotype and metabolite profiles— Cannabis sativa, Cannabis indica , and Cannabis ruderalis .
- decades of crossing and selection makes it impossible to absolutely characterize the resulting hybrid plants using phenotypic data.
- Most of the Cannabis varieties being sold for medicinal and recreational purposes contains characteristics of both Cannabis sativa and Cannabis indica subspecies. For this reason, ‘PG 1 19 0125 0002’, described herein, has been characterized both on the presented phenotype, as well as the genotype using a series of single nucleotide polymorphisms (SNP).
- SNP single nucleotide polymorphisms
- Cannabis plants synthesize unique terpeno-phenolic compounds in varying concentrations. High genetic variability has resulted in the vast varieties of chemotypes with distinct characteristics available today. More than 500 unique compounds including cannabinoids, terpenoids, terpenes, flavonoids, amino acids, vitamins among many others, are secreted as a sticky resin by the glandular trichomes found on the floral calyxes of female plants. Cannabinoids and terpenes are the biologically active chemicals responsible for the pharmacological and psychoactive properties of Cannabis when consumed by humans. They often work together synergistically in what is commonly known as the “entourage effect” and as such, small differences in composition or concentration any of these compounds can have notable effects on the physiological effect of consumed or applied Cannabis in or on the human body.
- Cannabinoids are produced at significant concentrations in Cannabis . Although over a hundred cannabinoids have been identified in Cannabis , the major cannabinoids include, ⁇ 9-tetrahydrocannabinol (THC), cannabidiol (CBD), cannabigerol (CBG), cannabinol (CBN), cannabichromene (CBC), cannabinodiol (CBDL), cannabicyclol (CBL), cannabivarin (CBDV), cannabigerovarin (CBGV), cannabichromevarin (CBCV), tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), cannabigerol monomethyl ether (CBGM), cannabilsoin (CBE), cannabicitran (CBT), cannabinol propyl variant (CBNV), cannabitriol (CBO), tetrahydrocannabinolic acid
- CBGA is the precursor to CBDA and THCA.
- CBG is usually present at very low concentrations due to its rapid utilization by CBDA or THCA synthases. It is non-psychoactive and has been described to display analgesic, antibiotic and anti-inflammatory effects. It has further been shown to reduce blood clotting and to relieve the intraocular pressure experienced by glaucoma patients. CBG further reduces the effect of THC and is actively being studied in its acid and neutral forms in many medical conditions.
- CBG will refer to both the decarboxylated form, CBG, and CBGA.
- Total THC and CBD are similarly calculated but with a conversion factor of 87.7%.
- Terpenes are organic molecules produced by various plants and animals. These organic compounds are responsible for the strong and distinctive smell and taste of Cannabis . Some of the most prominent terpenes found in Cannabis are myrcene, caryophyllene, and limonene, to mention a few.
- the objective of the breeding program that produced ‘PG 1 19 0125 0002’ was to develop Cannabis plant varieties with unique combinations of cannabinoids and/or terpenes, while displaying a phenotype with multiple large inflorescences arranged in a naturally branched habit.
- the variety described herein is a result of this breeding program.
- the ‘PG 1 19 0125 0002’ cultivar was the result of poly-cross between several hemp-type and high CBD-type Cannabis plants. Selected progenies were then cloned and crossed by selfing using methods known in the art. In subsequent generations, the resultant plants were screened for high total CBG production and selected based on production-relevant phenotypes. The progeny with the most stable desirable chemotype was assigned the name, ‘PG 1 19 0125 0002’.
- the ‘PG 1 19 0125 0002’ plants described herein were grown in Zeiningen, Switzerland, in nurseries, climate-controlled growth facilities, and in the field during the summer of 2019. Samples for metabolite analysis were taken from the flowers of numerous plants. Analytical measurements were made using Ultra Performance Liquid Chromatography by those skilled in the art. Plant phenotyping was performed using photography and subsequent analysis.
- the ‘PG 1 19 0125 0002’ variety described herein is extremely low in contaminating cannabinoids such as THC and CBD allowing for easier extraction of the CBG contained in the flowers.
- cannabinoids such as THC and CBD allowing for easier extraction of the CBG contained in the flowers.
- the low THC concentration facilitates extraction in that cannabinoids can be concentrated to a higher level, during the extraction process.
- ‘PG 1 19 0125 0002’ flowers were analyzed at harvest in both indoor growth and outdoor growth environments (Table 1).
- the resultant cannabinoid profile highlights the uniquely high CBG, and low THC and CBD content characterizing the ‘PG 1 19 0125 0002’ variety. It has a cannabinoid profile in the dried mature female flowers that is dominant in CBG (>5% w/w) and displays only trace amounts of THC ( ⁇ 0.1% w/w) and CBD ( ⁇ 0.1% w/w).
- ‘PG 1 19 0125 0002’ presents with a low total terpene content.
- the total measurable terpene content is between 0.05 and 0.07% (w/w) in the fresh flowers, and between 0.9 and 0.12% (w/w) in dried flowers.
- the dominant terpene found in fresh flowers is Myrcene followed by trans-Caryophyllene and Limonene (Table 2).
- the unique profile of the major and minor terpenes makes ‘PG 1 19 0125 0002’ distinguishable from other varieties, including Santhica 27 and PG_1_Pre-19_0125_0004.
- the genotype of ‘PG 1 19 0125 0002’ was characterized using Genotyping-by-sequencing (GBS) using methods described in the art. Short-read sequencing data produced by this method were aligned to the publicly available assembled genome of cs10 (Assembly: GCF_900626175.1) to identify single nucleotide polymorphisms (SNP) and short haplotypes (HAP, a combination of linked SNPs) in ‘PG 1 19 0125 0002’ (Table 3 and FIG. 14 ).
- Table 3 shows a list of single nucleotide polymorphisms (SNPs) and haplotypes (HAPs) contained within the genome of ‘PG 1 19 0125 0002’ compared to the publicly available reference genome of cs10 (Assembly: GCF_900626175.1). Each record shows the reference chromosome of cs10, the nucleotide position on the cs10 reference sequence, the nucleotide sequence at this position, the nucleotide sequence displayed in ‘PG 1 19 0125 0002’, and whether the state of the polymorphism is homozygous or heterozygous in ‘PG 1 19 0125 0002’. Heterozygous loci contain one allele sequence identical to the reference nucleotide sequence and one allele of the ‘PG 1 19 0125 0002’ sequence.
- SNPs single nucleotide polymorphisms
- HAPs haplotypes
- ‘PG 1 19 0125 0002’ may have medicinal applications in the treatment of certain cancer types, pain, infection and inflammation, Glaucoma and cardiovascular disease.
- Asexual or vegetative propagation methods are well-known to those skilled in the art.
- ‘PG 1 19 0125 0002’ is cloned according the following method: Coco peat plugs are soaked in pH adjusted water and kept warm. Cuttings measuring 10-12 cm are taken 3 nodes from the branch distal meristem and trimmed of lower leaves. The cuttings are dipped in water and a commercial rooting agent and inserted into the warmed plugs. Trays are kept in continuous light conditions and high humidity for 7 to 15 days until rooted. Rooted plants may be transferred directly into the field for outdoor growth or used for indoor growth. The initial asexual propagation took place in Zeiningen, Switzerland.
- Rooted clones are transferred to two-gallon pots containing growth medium consisting of a mixture of soil, peat and pearlite in a ratio of 3:3:1.
- Plants are grown in an indoor growth hall under completely supplied artificial high-pressure sodium (HPS) lighting (E-Papillon, 1000W, 400V). The air in the room was circulated with a fan and the humidity was kept constant at 45-55%.
- Commercial fertilizer is applied at a dose of 70-80% of the amount recommended by the manufacturer (Plagron, NL).
- the plants are grown for 10 days with a light intensity between 700-800 ⁇ mol m ⁇ 2 s- 1 , 18 h light/6 h dark day-night photoperiod with a 24-25° C. day/18° C. night temperature.
- the photoperiod is then changed to a 12 h light/12 h dark day-night cycle and the light intensity increased by 100 ⁇ mol m ⁇ 2 s ⁇ 1 per day for 7 days, at 25° C. day/23° C. night temperatures.
- the light intensity is adjusted to 1400-1500 ⁇ mol m ⁇ 2 s ⁇ 1 with a 12 h light/12 h dark day-night photoperiod and a 24-25° C. day/18° C. night temperature.
- the flowers are harvested.
- FIG. 1 Representative pictures of the ‘PG 1 19 0125 0002’ flower phenotype when grown under indoor conditions (10 days before harvest).
- FIG. 2 ‘PG 1 19 0125 0002’, indoor grown, growth pattern during vegetative growth phase.
- A-C and D-F represent individual plants photographed from increasing inclination for descriptive purposes. Both plants were photographed 28-35 days after cloning. Ruler for scale with cm markings.
- FIG. 3 ‘PG 1 19 0125 0002’, indoor grown, growth pattern during flowering.
- A-C and D-F represent individual plants photographed from increasing inclination for descriptive purposes. Both plants were photographed 1-3 days prior to harvest. Ruler for scale with cm markings.
- FIG. 4 ‘PG 1 19 0125 0002’ indoor grown growth pattern during flowering.
- a and D are a single plant representing the most common flower structure observed.
- B and C and individual flowers showing less common but observed flower structure phenotypes. Plants were photographed 1-3 days prior to harvest.
- FIG. 5 ‘PG 1 19 0125 0002’ leaves emerge a very dark green and lighten towards yellow during development.
- A Five leaves throughout indoor grown development.
- B Leaf 3-5 days after emergence.
- C-E Leaves through development but before flower maturation.
- F Senescent leaf after flower maturation. Photos include ruler measures with cm markings and appropriate Pantone swatch for color comparison.
- FIG. 6 ‘PG 1 19 0125 0002’ stem sections from a single plant illustrating a filled/solid stem and not a hollow one common in other varieties. (Left) Section below the first node on the primary stem, closest to soil level. (Center left) Primary branch. (Center right and right) Flower bearing terminal branches. Ruler for scale with cm markings.
- FIG. 7 Four representative flowers of indoor grown ‘PG 1 19 0125 0002’ illustrating the typical development of the stigma coloration which begins a very light green and turn a deep red-brown during maturation.
- A-C Identical flowers photographed with varied Pantone swatches for color comparison. Ruler for scale with cm markings.
- FIG. 8 Three representative branches of an individual indoor grown ‘PG 1 19 0125 0002’ prior to harvest. (A) All three branches photographed together. (B-D) The same branches photographed individually. Branches are photographed with varied Pantone swatches for color comparison and with a ruler with cm markings for scale.
- FIG. 9 A single branch of indoor grown ‘PG 1 19 0125 0002’ showing immature flowers.
- A The branch with leaves intact showing the ventral red coloration of the petioles.
- B The same branch manually defoliated around the apical flowers.
- C A closer image to illustrate the length and color of the stigma at this mid flower developmental stage. Branches are photographed with varied Pantone swatches for color comparison and with a ruler with cm markings for scale.
- FIG. 11 ‘PG 1 19 0125 0002’, glasshouse grown, growth pattern during flowering.
- A Side view of a ‘PG 1 19 0125 0002’ flower 10 days prior to harvest.
- B-D An individual plant photographed early in floral development to show the (B) apical flower,
- C a side view of the whole plant,
- D a view of the apical inflorescence. Ruler for scale with cm markings.
- FIG. 12 ‘PG 1 19 0125 0002’ growth pattern during flowering while grown outdoors near Möhlin, Switzerland.
- A Side view of the apical inflorescence 14 days prior to harvest.
- B A closer image of the apical flower.
- C A side view of the apical inflorescence visualizing the dense trichomes on the flowers.
- FIGS. 13A-C FIG. 13A Annual global radiation, FIG. 13B sunshine and FIG. 13C temperatures in Möhlin, the closest weather station to the breeding site of ‘PG 1 19 0125 0002’. Data range shown is from November 2018 to November 2019. Data courtesy of the Swiss Federal Office of Meteorology and Climatology.
- FIG. 14 A graphical representation of the single nucleotide polymorphisms (SNP) and haplotypes (HAPs) contained within the genome of ‘PG 1 19 0125 0002’ when compared to the publicly available reference genome of cs10 (Assembly: GCF_900626175.1) and shown in Table 2.
- the chromosomal reference sequence of cs10 is shown on the left and the approximate nucleotide position of the cs10 reference sequence is shown below. Homo- and heterozygous sequence variants are indicated as black and red dots, respectively.
- Plants used for the botanical description of the plant are annual, herbaceous, upright, tap-rooted plants. They are Cannabis hybrid species and the particular variety described herein is designated the name ‘PG 1 19 0125 0002’.
- ‘PG 1 19 0125 0002’ is a cross between multiple pollen donors and several pollen acceptors of both hemp-type and high CBD-type Cannabis plants. The initial cross was made during April 2018. The resultant F1 seeds were grown, cloned, and the clones used for crossing i.e. selfed. The F2 seed was grown, and from this population ‘PG 1 19 0125 0002’ was selected. The selection criteria were based on the following characteristics: Maximal CBG content and minimal THC and CBD content in the mature flower, flower density, and a highly branched plant structure. The variety was first vegetatively reproduced on the 12 th of April 2019 and the resultant plants screened for high total CBG production and selected based on production relevant phenotypes. The progeny with the most stable desirable chemotype was assigned the name, ‘PG 1 19 0125 0002’. ‘PG 1 19 0125 0002’ continues to be vegetatively reproduced by cloning in Zeiningen, Switzerland.
- ‘PG 1 19 0125 0002’ is short and highly branched with large flowers on each branch, reaching a maximum height of approximately 1 meter, whereas ‘Santhica 27’ is tall and mostly unbranched with a dominant apical inflorescence, reaching a height of up to 2.5 meters.
- ‘PG_1_Pre-19_0125_0004’ is a close relative of ‘PG 1 19 0125 0002’ from the Pure Cannabis Research breeding program and displays an almost identical growth pattern and general phenotype. A clear difference between the two varieties can be seen in their cannabinoid profiles (See Table 1 above). The cannabinoid profile of the ‘PG_1_Pre-19_0125_0004’ flower is clearly CBD-dominant with significant THCA accumulation.
- the ‘PG 1 19 0125 0002’ cultivar is a mixed hybrid of the Cannabis sp. It is naturally obtained and not the result of any genetic modification techniques.
Landscapes
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
A new and distinct Cannabis cultivar named ‘PG 1 19 0125 0002’ is characterized by its dominant CBG chemotype, which is favorable for application as a medicinal product. Furthermore, it may be used for the industrial-scale extraction of CBG due to the minimal concentrations of contaminating cannabinoids which may otherwise complicate the extraction of this class of secondary metabolites.
Description
Latin name of the genus claimed: Cannabis Hybrid.
Variety denomination: ‘PG 1 19 0125 0002’.
A novel Cannabis hybrid cultivar, entitled ‘PG 1 19 0125 0002’ is provided. ‘PG 1 19 0125 0002’ is the result of a planned breeding program and originated from crosses between privately-owned cultivars. The new cultivar has been vegetatively reproduced by cloning using stem cuttings at Zeiningen, Switzerland. Vegetative clones of ‘PG 1 19 0125 0002’ were tested in controlled indoor growth facilities, greenhouses, and outdoors in open fields. The desired characteristics of each source cultivar are transferred by vegetative, asexual reproduction. ‘PG 1 19 0125 0002’ is stable and consistently true-to-type through multiple generations of vegetative reproduction.
Cannabis is a genus of flowering plants comprising three historically distinct subspecies based on phenotype and metabolite profiles—Cannabis sativa, Cannabis indica, and Cannabis ruderalis. However, decades of crossing and selection makes it impossible to absolutely characterize the resulting hybrid plants using phenotypic data. Most of the Cannabis varieties being sold for medicinal and recreational purposes contains characteristics of both Cannabis sativa and Cannabis indica subspecies. For this reason, ‘PG 1 19 0125 0002’, described herein, has been characterized both on the presented phenotype, as well as the genotype using a series of single nucleotide polymorphisms (SNP).
Used herein, the terms “cultivar”, “variety”, “clone” and “strain” are used interchangeably.
Cannabis plants synthesize unique terpeno-phenolic compounds in varying concentrations. High genetic variability has resulted in the vast varieties of chemotypes with distinct characteristics available today. More than 500 unique compounds including cannabinoids, terpenoids, terpenes, flavonoids, amino acids, vitamins among many others, are secreted as a sticky resin by the glandular trichomes found on the floral calyxes of female plants. Cannabinoids and terpenes are the biologically active chemicals responsible for the pharmacological and psychoactive properties of Cannabis when consumed by humans. They often work together synergistically in what is commonly known as the “entourage effect” and as such, small differences in composition or concentration any of these compounds can have notable effects on the physiological effect of consumed or applied Cannabis in or on the human body.
Cannabinoids are produced at significant concentrations in Cannabis. Although over a hundred cannabinoids have been identified in Cannabis, the major cannabinoids include, Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), cannabigerol (CBG), cannabinol (CBN), cannabichromene (CBC), cannabinodiol (CBDL), cannabicyclol (CBL), cannabivarin (CBDV), cannabigerovarin (CBGV), cannabichromevarin (CBCV), tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), cannabigerol monomethyl ether (CBGM), cannabilsoin (CBE), cannabicitran (CBT), cannabinol propyl variant (CBNV), cannabitriol (CBO), tetrahydrocannabinolic acid (THCA), tetrahydrocannabivarinic acid (THCVA), cannabidiolic acid (CBDA), cannabigerolic acid (CBGA) and cannabinerolic acid. These cannabinoids are usually produced by the plant in their acid form (see suffix -A), but upon heating they become. decarboxylated.
CBGA is the precursor to CBDA and THCA. CBG is usually present at very low concentrations due to its rapid utilization by CBDA or THCA synthases. It is non-psychoactive and has been described to display analgesic, antibiotic and anti-inflammatory effects. It has further been shown to reduce blood clotting and to relieve the intraocular pressure experienced by glaucoma patients. CBG further reduces the effect of THC and is actively being studied in its acid and neutral forms in many medical conditions.
As used herein, CBG will refer to both the decarboxylated form, CBG, and CBGA. The value “Total CBG” will refer to the calculated sum of both isoforms when decarboxylated i.e. Total CBG=GBGA×87.8%+CBG. Total THC and CBD are similarly calculated but with a conversion factor of 87.7%.
Terpenes are organic molecules produced by various plants and animals. These organic compounds are responsible for the strong and distinctive smell and taste of Cannabis. Some of the most prominent terpenes found in Cannabis are myrcene, caryophyllene, and limonene, to mention a few.
The objective of the breeding program that produced ‘PG 1 19 0125 0002’ was to develop Cannabis plant varieties with unique combinations of cannabinoids and/or terpenes, while displaying a phenotype with multiple large inflorescences arranged in a naturally branched habit. The variety described herein is a result of this breeding program.
The ‘PG 1 19 0125 0002’ cultivar was the result of poly-cross between several hemp-type and high CBD-type Cannabis plants. Selected progenies were then cloned and crossed by selfing using methods known in the art. In subsequent generations, the resultant plants were screened for high total CBG production and selected based on production-relevant phenotypes. The progeny with the most stable desirable chemotype was assigned the name, ‘PG 1 19 0125 0002’.
The ‘PG 1 19 0125 0002’ plants described herein were grown in Zeiningen, Switzerland, in nurseries, climate-controlled growth facilities, and in the field during the summer of 2019. Samples for metabolite analysis were taken from the flowers of numerous plants. Analytical measurements were made using Ultra Performance Liquid Chromatography by those skilled in the art. Plant phenotyping was performed using photography and subsequent analysis.
The ‘PG 1 19 0125 0002’ variety described herein is extremely low in contaminating cannabinoids such as THC and CBD allowing for easier extraction of the CBG contained in the flowers. In addition, the low THC concentration facilitates extraction in that cannabinoids can be concentrated to a higher level, during the extraction process.
‘PG 1 19 0125 0002’ flowers were analyzed at harvest in both indoor growth and outdoor growth environments (Table 1). The resultant cannabinoid profile highlights the uniquely high CBG, and low THC and CBD content characterizing the ‘PG 1 19 0125 0002’ variety. It has a cannabinoid profile in the dried mature female flowers that is dominant in CBG (>5% w/w) and displays only trace amounts of THC (<0.1% w/w) and CBD (<0.1% w/w).
‘PG 1 19 0125 0002’ presents with a low total terpene content. In fresh flowers the total measurable terpene content is between 0.05 and 0.07% (w/w) in the fresh flowers, and between 0.9 and 0.12% (w/w) in dried flowers. The dominant terpene found in fresh flowers is Myrcene followed by trans-Caryophyllene and Limonene (Table 2). The unique profile of the major and minor terpenes makes ‘PG 1 19 0125 0002’ distinguishable from other varieties, including Santhica 27 and PG_1_Pre-19_0125_0004.
TABLE 1 |
Cannabinoid Concentrations in ‘ |
PG_1_Pre- | |||
‘ |
Santhica 27 | 19_0125_0004 |
Indoor | Outdoor | Outdoor | Outdoor | |
Flowers | Flowers | Flowers | Flowers |
Range of active cannabinoids (% by weight) | |
TOTAL CBG | 7.2-8.105 | 5.6-9.442 | 0.4-1.4 | 11.5-15.5 |
TOTAL THC | 0.07-0.13 | 0.053-0.13 | — | 0.45-0.75 |
TOTAL CBD | 0-0.03 | 0.001-0.21 | 0-0.2 | 0.85-1.34 |
CBC | 0.03-0.29 | 0.03-0.39 | — | 0-0.15 |
TABLE 2 |
Terpene Concentrations in ‘ |
Fresh Flowers | Dry Flowers |
Ranges of Terpenes (% by weight) | |||
alpha-Pinene | 0.000-0.001% | — | ||
(−)-beta-Pinene | 0.001-0.001% | — | ||
Myrcene | 0.028-0.031% | 0.010-0.012% | ||
(R)-(+)-Limonene | 0.004-0.006% | 0.001-0.002% | ||
p-Cymene | 0.00% | 0.005-0.008% | ||
Linalool | 0.001-0.003% | 0.00% | ||
L-Fenchone | — | 0.003-0.006% | ||
(+)-Fenchol | 0.00% | — | ||
(−)-Isopulegol | 0.000-0.001% | — | ||
(−)-alpha-Terpineol | 0.00% | — | ||
Citral Isomer 2 | 0.000-0.001% | 0.002-0.003% | ||
(−)-trans-Caryophyllene | 0.007-0.009% | 0.003-0.009% | ||
alpha-Humulene | 0.002-0.003% | 0.002-0.003% | ||
Nerolidol Isomer 2 | 0.001-0.004% | 0.004-0.009% | ||
(−)-alpha-Bisabolol | 0.003-0.004% | 0.009-0.016% | ||
Phytol Isomer 2 | 0.003-0.006% | 0.037-0.060% | ||
The genotype of ‘PG 1 19 0125 0002’ was characterized using Genotyping-by-sequencing (GBS) using methods described in the art. Short-read sequencing data produced by this method were aligned to the publicly available assembled genome of cs10 (Assembly: GCF_900626175.1) to identify single nucleotide polymorphisms (SNP) and short haplotypes (HAP, a combination of linked SNPs) in ‘PG 1 19 0125 0002’ (Table 3 and FIG. 14 ).
Together these polymorphisms provide a fingerprint which can be used to differentiate ‘PG 1 19 0125 0002’ from all other Cannabis varieties.
Table 3 shows a list of single nucleotide polymorphisms (SNPs) and haplotypes (HAPs) contained within the genome of ‘PG 1 19 0125 0002’ compared to the publicly available reference genome of cs10 (Assembly: GCF_900626175.1). Each record shows the reference chromosome of cs10, the nucleotide position on the cs10 reference sequence, the nucleotide sequence at this position, the nucleotide sequence displayed in ‘PG 1 19 0125 0002’, and whether the state of the polymorphism is homozygous or heterozygous in ‘PG 1 19 0125 0002’. Heterozygous loci contain one allele sequence identical to the reference nucleotide sequence and one allele of the ‘PG 1 19 0125 0002’ sequence.
TABLE 3 | ||||
Reference | Position in | Reference | ‘ |
|
chromosome | reference | nucleotide | 0125 0002’ | |
(cs10) | sequence | sequence | Sequence | State |
NC_044370.1 | 2085232 | AA | AT | homozygous |
NC_044370.1 | 4838286 | CGT | CGC | homozygous |
NC_044370.1 | 36467493 | C | T | homozygous |
NC_044370.1 | 11271773 | CA | CG | homozygous |
NC_044370.1 | 11271954 | CAG | AAG | homozygous |
NC_044370.1 | 13526608 | CAA | CTG | homozygous |
NC_044379.1 | 57862779 | C | T | homozygous |
NC_044379.1 | 57863241 | GGTAC | AAAGC | homozygous |
NC_044379.1 | 57915145 | TT | TC | homozygous |
NC_044379.1 | 57954931 | C | G | homozygous |
NC_044379.1 | 58169058 | GTG | CAA | homozygous |
NC_044379.1 | 58292575 | ATCCAA | GTCCCA | homozygous |
NC_044379.1 | 58292927 | T | C | homozygous |
NC_044379.1 | 26744250 | G | T | homozygous |
NC_044379.1 | 61946066 | A | G | homozygous |
NC_044379.1 | 62821655 | G | C | homozygous |
NC_044371.1 | 3483276 | ACG | ACA | homozygous |
NC_044371.1 | 66149411 | T | A | homozygous |
NC_044371.1 | 75422669 | TGA | CGT | homozygous |
NC_044371.1 | 75974152 | GCC | GTC | homozygous |
NC_044371.1 | 81582801 | TT | CT | homozygous |
NC_044371.1 | 82218848 | GAG | AGT | homozygous |
NC_044371.1 | 82483522 | GC | AA | homozygous |
NC_044371.1 | 30915413 | A | G | homozygous |
NC_044372.1 | 2710529 | T | C | homozygous |
NC_044372.1 | 2710755 | TG | CG | homozygous |
NC_044372.1 | 80252454 | G | T | homozygous |
NC_044372.1 | 1890501 | T | C | homozygous |
NC_044373.1 | 7589246 | CA | GA | homozygous |
NC_044373.1 | 16326218 | AA | GG | homozygous |
NC_044373.1 | 18857773 | T | G | homozygous |
NC_044373.1 | 26968201 | TCC | TCT | homozygous |
NC_044373.1 | 29630917 | G | A | homozygous |
NC_044373.1 | 44999598 | C | T | homozygous |
NC_044373.1 | 46220665 | CT | TG | homozygous |
NC_044373.1 | 65997446 | C | T | homozygous |
NC_044373.1 | 65997630 | A | G | homozygous |
NC_044373.1 | 78468284 | G | C | homozygous |
NC_044373.1 | 90475592 | AAGG | AAAA | homozygous |
NC_044373.1 | 91302456 | ATAA | CTAA | homozygous |
NC_044374.1 | 721191 | GC | CC | homozygous |
NC_044374.1 | 2380328 | T | A | homozygous |
NC_044374.1 | 7842585 | C | T | homozygous |
NC_044374.1 | 46733863 | T | A | homozygous |
NC_044374.1 | 81289150 | C | T | homozygous |
NC_044374.1 | 87026417 | CT | GT | homozygous |
NC_044374.1 | 53042056 | C | G | homozygous |
NC_044374.1 | 75148552 | C | T | homozygous |
NC_044374.1 | 79606305 | GCG | CTA | homozygous |
NC_044374.1 | 40728787 | A | G | homozygous |
NC_044374.1 | 81665769 | ATGC | ATGT | homozygous |
NC_044375.1 | 93189088 | A | G | homozygous |
NC_044375.1 | 5028137 | CGT | TGT | homozygous |
NC_044375.1 | 5229457 | TAT | CAT | homozygous |
NC_044375.1 | 92418831 | AGCC | AACC | homozygous |
NC_044375.1 | 36259780 | GA | GC | homozygous |
NC_044375.1 | 27969778 | GA | GG | homozygous |
NC_044375.1 | 47220146 | C | G | homozygous |
NC_044376.1 | 3765575 | CCT | TTT | homozygous |
NC_044376.1 | 4038278 | AGG | CAG | homozygous |
NC_044376.1 | 35656963 | TGG | CGA | homozygous |
NC_044376.1 | 41113525 | GACG | GTCG | homozygous |
NC_044376.1 | 49690671 | A | G | homozygous |
NC_044376.1 | 57526518 | TC | GC | homozygous |
NC_044376.1 | 61093783 | TA | AG | homozygous |
NC_044377.1 | 491424 | CTG | CAT | homozygous |
NC_044377.1 | 570205 | TCT | AAT | homozygous |
NC_044377.1 | 22400517 | A | G | homozygous |
NC_044377.1 | 29225173 | T | A | homozygous |
NC_044377.1 | 36155194 | AGG | CGG | homozygous |
NC_044377.1 | 44377730 | GG | CG | homozygous |
NC_044377.1 | 53006255 | A | T | homozygous |
NC_044377.1 | 61322716 | AGC | AAA | homozygous |
NC_044377.1 | 72446888 | G | A | homozygous |
NC_044377.1 | 78287396 | TTGTC | GTGTC | homozygous |
NC_044378.1 | 108801 | TT | TC | homozygous |
NC_044378.1 | 459898 | TATA | TTCA | homozygous |
NC_044378.1 | 19944962 | GC | AG | homozygous |
NC_044378.1 | 23972788 | CT | CA | homozygous |
NC_044378.1 | 29436763 | CCCCCC | ACCCTT | homozygous |
NC_044378.1 | 46687062 | GGCG | GGCA | homozygous |
NC_044378.1 | 53550861 | CAGG | TGGA | homozygous |
NC_044378.1 | 63538044 | GT | GA | homozygous |
NC_044378.1 | 66753962 | GGGT | GAGT | homozygous |
NC_044370.1 | 72116963 | CC | TT | heterozygous |
NC_044370.1 | 104558715 | AC | CC | heterozygous |
NC_044371.1 | 42597265 | TT | TC | heterozygous |
NC_044372.1 | 35317415 | CTC | GTC | heterozygous |
NC_044372.1 | 63982910 | GGCG | GCCG | heterozygous |
NC_044375.1 | 69785254 | GCG | TTA | heterozygous |
NC_044379.1 | 12989226 | CT | TC | heterozygous |
NC_044379.1 | 41567327 | CAAAC | ATTGC | heterozygous |
End of Table 2. | ||||
Based on the chemotype, past research shows that ‘PG 1 19 0125 0002’ may have medicinal applications in the treatment of certain cancer types, pain, infection and inflammation, Glaucoma and cardiovascular disease.
Asexual or vegetative propagation methods (also known as cloning) are well-known to those skilled in the art. ‘PG 1 19 0125 0002’ is cloned according the following method: Coco peat plugs are soaked in pH adjusted water and kept warm. Cuttings measuring 10-12 cm are taken 3 nodes from the branch distal meristem and trimmed of lower leaves. The cuttings are dipped in water and a commercial rooting agent and inserted into the warmed plugs. Trays are kept in continuous light conditions and high humidity for 7 to 15 days until rooted. Rooted plants may be transferred directly into the field for outdoor growth or used for indoor growth. The initial asexual propagation took place in Zeiningen, Switzerland.
It was observed that all of the desired characteristics of each clone are transferred by vegetative reproduction in a consistent and uniform fashion. The characteristics of ‘PG 1 19 0125 0002’ are stable and the variety remains true-to-type through multiple generations of vegetative reproduction.
Rooted clones are transferred to two-gallon pots containing growth medium consisting of a mixture of soil, peat and pearlite in a ratio of 3:3:1. Plants are grown in an indoor growth hall under completely supplied artificial high-pressure sodium (HPS) lighting (E-Papillon, 1000W, 400V). The air in the room was circulated with a fan and the humidity was kept constant at 45-55%. Commercial fertilizer is applied at a dose of 70-80% of the amount recommended by the manufacturer (Plagron, NL). The plants are grown for 10 days with a light intensity between 700-800 μmol m−2 s-1, 18 h light/6 h dark day-night photoperiod with a 24-25° C. day/18° C. night temperature. The photoperiod is then changed to a 12 h light/12 h dark day-night cycle and the light intensity increased by 100 μmol m−2 s−1 per day for 7 days, at 25° C. day/23° C. night temperatures. During the following 60 days the light intensity is adjusted to 1400-1500 μmol m−2 s−1 with a 12 h light/12 h dark day-night photoperiod and a 24-25° C. day/18° C. night temperature. After a total of 84-91 days of growth after cloning, the flowers are harvested.
Field growth of ‘PG 1 19 0125 0002’ was performed in Zeiningen, Switzerland during the summer of 2019. The weather during the year of 2019 is presented in FIG. 13 . Rooted clones were planted in the field on the 1st of July 2019. Mature flowers were then collected during the first two weeks of October.
‘PG 1 19 0125 0002’ was grown in Zeiningen, Switzerland and observations were made in the field, in nursery glasshouses as well as in climate controlled indoor growth facilities. Observed phenotypes may vary in different environmental conditions.
Plants used for the botanical description of the plant are annual, herbaceous, upright, tap-rooted plants. They are Cannabis hybrid species and the particular variety described herein is designated the name ‘PG 1 19 0125 0002’.
Throughout this specification, color names beginning with a small letter signify that the name of that color, as used in common speech is aptly descriptive. Color number descriptions were obtained using the Pantone Plus Series Color Bridge (ISBN: 978 1-590651-59-9).
‘PG 1 19 0125 0002’ is a cross between multiple pollen donors and several pollen acceptors of both hemp-type and high CBD-type Cannabis plants. The initial cross was made during April 2018. The resultant F1 seeds were grown, cloned, and the clones used for crossing i.e. selfed. The F2 seed was grown, and from this population ‘PG 1 19 0125 0002’ was selected. The selection criteria were based on the following characteristics: Maximal CBG content and minimal THC and CBD content in the mature flower, flower density, and a highly branched plant structure. The variety was first vegetatively reproduced on the 12th of April 2019 and the resultant plants screened for high total CBG production and selected based on production relevant phenotypes. The progeny with the most stable desirable chemotype was assigned the name, ‘PG 1 19 0125 0002’. ‘PG 1 19 0125 0002’ continues to be vegetatively reproduced by cloning in Zeiningen, Switzerland.
When ‘PG 1 19 0125 0002’ is compared to the Cannabis variety ‘Santhica 27’ (UPOV grant number: 1004490), some similarities and many distinct characteristics become apparent. Both ‘PG 1 19 0125 0002’ and ‘Santhica 27’ present with CBG as the dominant cannabinoid, with extremely low THC and CBD levels. ‘PG 1 19 0125 0002’, however, displays a up to six times more CBG in dried flowers than ‘Santhica 27’. Moreover, the ‘PG 1 19 0125 0002’ flowers develop into a significantly denser inflorescence. Morphologically, ‘PG 1 19 0125 0002’ is short and highly branched with large flowers on each branch, reaching a maximum height of approximately 1 meter, whereas ‘Santhica 27’ is tall and mostly unbranched with a dominant apical inflorescence, reaching a height of up to 2.5 meters. The characteristics listed above, including branching, flower density, and significantly more CBG per unit mass, results in the ‘PG 1 19 0125 0002’ variety presenting with a substantially higher harvest index than ‘Santhica 27’ with respect to CBG production.
‘PG_1_Pre-19_0125_0004’ is a close relative of ‘PG 1 19 0125 0002’ from the Pure Cannabis Research breeding program and displays an almost identical growth pattern and general phenotype. A clear difference between the two varieties can be seen in their cannabinoid profiles (See Table 1 above). The cannabinoid profile of the ‘PG_1_Pre-19_0125_0004’ flower is clearly CBD-dominant with significant THCA accumulation.
Below is a detailed description of the new variety ‘PG 1 19 0125 0002’ (See also Table 3, above). Unless otherwise stated measurements were taken from plants grown indoors at various stages of development up to 11 weeks after cloning.
The ‘PG 1 19 0125 0002’ cultivar is a mixed hybrid of the Cannabis sp. It is naturally obtained and not the result of any genetic modification techniques.
- Plant:
-
- Plant life form and growth habit.—An annual herbaceous plant described as broad, upright, tap-rooted.
- Plant propagation.—Asexually propagated by cutting and cloning methods.
- Propagation ease.—‘
PG 1 19 0125 0002’ is easy to propagate. - Height.—Approximately 50 cm to 100 cm.
- Width.—Approximately 30 cm to 50 cm.
- Plant vigor.—Medium — ‘
PG 1 19 0125 0002’ bears large flowers without the requirement for excessive growth. - Time to harvest.—From time of cloning the plant will take approximately 8 weeks to be harvest-ready.
- Resistance to pathogens.—Partial resistance. It is known to be moderately susceptible to Botrytis.
- Genetic modification.—It is naturally obtained and not the result of any genetic modification techniques.
- Conditions of flowering.—‘
PG 1 19 0125 0002’ flowers once the daylight period is reduced to 12 hours daylight. - Hardiness.—‘
PG 1 19 0125 0002’ easily tolerates temperatures up to 26° C. - Breaking action.—This variety has a sturdy main stem with a “pithy” center. It is not highly flexible, but resistant to breaking. The flexible side branches are highly resistant to breaking.
- Rooting behavior.—When propagated according to PureGene's standard operating procedures, it roots vigorously at a rate of 98% within 7-10 days.
-
- Leaf:
-
- Arrangement.—Alternating.
- Shape.—Palmately compound.
- Structure.—Leaflet blades are very elongated, elliptical, lanceolate with acute tips and bases.
- Margins.—Serrated with teeth pointing toward the leaflet tips.
- Hairs.—Extremely fine sericreous hairs pointing toward the leaf tips.
- Mature leaf measurements.—Leaf length with petiole: Approximately 23 cm. Petiole length: Approximately 5 cm. Stipule length and shape: Approximately 0.4 cm to 1.5 cm linear with acute tip. Leaflet number: About 3 to 9. Middle leaflet length: width: Approximately 14:3. Teeth on middle leaflet: Approximately 15 to 30. Width of central leaflets: Approximately 30 mm to 35 mm for plants grown in indoors conditions.
- Leaflet apex shape.—Acuminate acute.
- Adaxial leaf trichomes (upper and lower surface).—capitate stalked, capitate sessile and cystolithic trichomes.
- Abaxial leaf trichomes (upper and lower surface).—Capitate stalked, capitate sessile and cystolithic trichomes.
- Abaxial petiole color range.—About Pantone 380-383 UP with gradual anthocyanin coloration of 7624 U and UP during flowering.
- Adaxial petiole color range.—About Pantone 382-385 UP with gradual anthocyanin coloration of 7624 U and UP during flowering.
- Stipule color range.—About Pantone 382-384 UP.
- Leaf color of the adaxial surface.—About Pantone 347-349 UP, 7734-7745 UP (leaf color changes from very dark green to the yellow spectrum with age).
- Leaf color of the abaxial surface.—Pantone 345-347 UP-7730 UP) The lower surface of the leaf changes from a dark green to light yellow spectrum with age.
- Leaf glossiness.—Average, becoming more matt at the apical ends as flowers mature.
- Midrib shape.—Prominent and continuous throughout each leaflet.
- Midrib color.—The midrib is a dark green, similar in shade to a younger leaf. As the leaf lightens with maturity, the midrib remains a dark green color (Pantone 349 UP).
- Aroma.—Earthy with citrus and fruit.
-
- Stem:
-
- Shape.—The stem is ribbed with a solid center.
- Diameter.—Approximately 2 cm to 5 cm.
- Color.—Varying shades of about light green depending on age (Pantone 7488 UP).
- Main stem groove.—Longitudinally ridged with medium grooves in immature stem, axillary branches, and mature branches proximal to flowering ends. Grooves gradually smooth out on older parts of the stem which, at maturity, are smooth and woody with a solid pith.
- Stem trichomes.—Capitate sessile glandular trichomes and unicellular non-glandular trichomes. Only unicellular non-glandular trichomes on the older, smooth parts of the stem.
- Stem internode length.—Short during early vegetative phases elongating as the plant matures. During late vegetative phase the average length of the internodes is medium. The internodes shorten exponentially towards the flowering ends exhibiting as very short directly below the compound inflorescence.
-
- Inflorescence:
-
- Flowering habit.—During vegetative phase individual flowers occur at nodes along the stem and branches. Upon flower initiation flowers appear as clusters, or compound inflorescences, as a result of higher order branching and shortened internodes. Terminal inflorescences appear as compressed and dense while more distal inflorescences gradually decrease in size and density with a scattered appearance.
- Proportion of female flowers.—100%.
- Inflorescence position.—Above.
- Flower arrangement.—Individual flowers (bracteoles) on each mature, compound inflorescence are tightly packed, congested, concentrated and crowded, touching and overlapping with stigmas curling over adjacent bracteoles with maturity.
- Number of flowers per plant.—About 50 to 100.
- Individual flower shape.—Each individual flower has one ovary enclosed in an urceolate bract with two long filiform stigmas protruding from each ovary and exiting above the bract.
- Compound inflorescence shape.—Compound inflorescences are ovaloid in shape with bilateral symmetry.
- Flower compound inflorescence diameter.—The average diameter around the terminal flower compound is 6 cm to 20 cm.
- Pistil length.—The length from the base of the ovary to the tips of the stigmas is approximately 2 cm to 10 cm.
- Style length.—There is no discernible style connecting the stigmas to the ovary. The stigma refers to the entire length from the upper curve of the ovary to the tip of the stigmas.
- Bract shape and color.—Urceolate and about dark green (Pantone 7731 UP).
- Stigma shape.—Extremely elongated, elliptical, filiform and visible as hair-like filaments on the surface of flower compounds.
- Stigma length (from the upper surface of the ovary to the tip of the stigma).—Approximately 2 mm to 10 mm.
- Stigma color.—The color changes from a about white/light green (Pantone 7485 UP) to about deep red-brown (Pantone 167 UP) as the flowers mature.
- Trichome color.—Initially clear becoming cloudy/milky white and then developing an amber color about Pantone 475 UP at 5 weeks post flowering.
- Trichome shape.—All flowering parts including the bracteoles and bracts are covered in capitate stalked, capitate sessile and bulbous glandular trichomes.
- Terminal bud shape.—Acute ovoid.
- Terminal bud color.—At maturity the terminal bud appears about dark green (Pantone 7731 UP) partially covered by deep red-brown (Pantone 167 UP) hair-like stigmas.
- Male flower characteristics.—‘
PG 1 19 0125 0002’ clones are propagated only as females and the male flower characteristics are not relevant to the physical botanical characterization of this variety. - Cannabinoid contents.—CBGmax—9.44%, CBDmax—0.21%, THCmax—0.13%.
- Flower fragrance.—Earthy with citrus notes in line with the presence of limonene in the terpene profile.
- Flower shipping quality.—It is a dense appealing flower when trimmed, cured and packaged according to quality guidelines. Dry flowers are of high quality and suitable as a direct-to-consumer commodity.
- Flower storage life.—A minimum of 1 year if packaged according to quality guidelines.
- Flower indoor productivity.—Approximately 0.9 g/watts.
- Flowering season.—In Zeiningen flowering is initiated around 11 August when the daylength reduces to 14.25 h. This may be different at different latitudes.
-
- Seed:
-
- Shape.—Solitary, ovoid and slightly compressed.
- Size.—Lateral: Approximately 3 mm. Longitudinal: Approximately 4 mm.
- Color of the testa.—Variable but generally a mottled brown-gray color ranging from About Pantone 4515 U at the light scale to 7532 UP at the dark scale with very dark brown about Pantone 7533 UP to black speckling.
-
Claims (1)
1. A new and distinct variety of Cannabis plant named ‘PG 1 19 0125 0002’, substantially as illustrated and described herein.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/873,352 USPP33391P2 (en) | 2020-03-26 | 2020-03-26 | Cannabis plant named ‘PG 1 19 0125 0002’ |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/873,352 USPP33391P2 (en) | 2020-03-26 | 2020-03-26 | Cannabis plant named ‘PG 1 19 0125 0002’ |
Publications (1)
Publication Number | Publication Date |
---|---|
USPP33391P2 true USPP33391P2 (en) | 2021-08-24 |
Family
ID=77390003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/873,352 Active USPP33391P2 (en) | 2020-03-26 | 2020-03-26 | Cannabis plant named ‘PG 1 19 0125 0002’ |
Country Status (1)
Country | Link |
---|---|
US (1) | USPP33391P2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230093798P1 (en) * | 2021-09-22 | 2023-03-23 | Umami Worldwide, LLC | Cannabis plant named 'afz' |
US20230093799P1 (en) * | 2021-09-22 | 2023-03-23 | Umami Worldwide, LLC | Cannabis plant named 'zlt' |
WO2023248150A1 (en) * | 2022-06-21 | 2023-12-28 | Puregene Ag | Quantitative trait locus associated with a flower density trait in cannabis |
WO2024033886A3 (en) * | 2022-08-11 | 2024-05-30 | Puregene Ag | Quantitative trait locus associated with a pathogen resistance trait in cannabis |
-
2020
- 2020-03-26 US US16/873,352 patent/USPP33391P2/en active Active
Non-Patent Citations (1)
Title |
---|
International Code of Nomenclature for Cultivated Plants 2016 Ninth ed., 2 introductory pages, iii, iv, pp. 28-32. (Year: 2016). * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230093798P1 (en) * | 2021-09-22 | 2023-03-23 | Umami Worldwide, LLC | Cannabis plant named 'afz' |
US20230093799P1 (en) * | 2021-09-22 | 2023-03-23 | Umami Worldwide, LLC | Cannabis plant named 'zlt' |
USPP35667P3 (en) * | 2021-09-22 | 2024-02-27 | Umami Worldwide, LLC | Cannabis plant named ‘AFZ’ |
USPP35668P3 (en) * | 2021-09-22 | 2024-02-27 | Umami Worldwide, LLC | Cannabis plant named ‘ZLT’ |
WO2023248150A1 (en) * | 2022-06-21 | 2023-12-28 | Puregene Ag | Quantitative trait locus associated with a flower density trait in cannabis |
WO2024033886A3 (en) * | 2022-08-11 | 2024-05-30 | Puregene Ag | Quantitative trait locus associated with a pathogen resistance trait in cannabis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USPP33391P2 (en) | Cannabis plant named ‘PG 1 19 0125 0002’ | |
US20160360721A1 (en) | Cannabis sativa plants rich in cannabichromene and its acid, extracts thereof and methods of obtaining extracts therefrom | |
USPP27475P2 (en) | Cannabis plant named ‘Ecuadorian Sativa’ | |
USPP31707P3 (en) | Cannabis plant named ‘GRAPE LOLIPOP’ | |
USPP30639P2 (en) | Hemp plant named ‘CW2A’ | |
USPP35571P2 (en) | Cannabis plant named ‘AC/DC x Redneck Wedding 13’ | |
Lyrene | Breeding cultivars from blueberry× deerberry hybrids: progress and prospects | |
USPP35718P2 (en) | Cannabis plant named ‘Pure Red 3’ | |
USPP34828P2 (en) | Hemp plant named ‘3 Crop’ | |
USPP33143P2 (en) | Cannabis ruderalis + Humulus lupulus plant named ‘ANEW’ | |
Yamamoto et al. | Effects of Photoperiod on Vegetative Growth, Flowering and Fruiting of Capsicum frutescens L. and C. annuum L. in Japan | |
USPP33162P3 (en) | Hemp plant named ‘Eighty Eight’ | |
USPP30434P3 (en) | Cannabis plant named ‘LW-BB1’ | |
Hofmann et al. | Caprifoliaceae (with Zabelia incert. sed.) Caprifoliaceae Juss., Gen. Pl. 210 (1789), nom. cons. Diervillaceae (Raf.) Pyck, Taxon 47: 658 (1998). Linnaeaceae (Raf.) Backlund, Taxon 47: 658 (1998). | |
Guan et al. | New germplasm for breeding: Pink-flowered and white-fruited strawberry | |
US11871721B2 (en) | Grapevines and related methods of production and use | |
USPP35260P2 (en) | Mint plant named ‘MP18’ | |
USPP22865P3 (en) | Penstemon plant named ‘Red Headed Beauty’ | |
Ganga et al. | Jasmine | |
USPP36307P3 (en) | Cannabis plant named ‘21AF0716’ | |
Ganga et al. | Jasmine 15 | |
Hayati et al. | Phenotypic Variability of The S2 Families Derived from Crosses Between Local and Introduced Okra Cultivars | |
USPP21289P3 (en) | Hop plant named ‘HBC 394’ | |
Datta | Mutation Work on Other Ornamental Plants | |
ASĂNICĂ et al. | MORPHOLOGICAL TRAITS OF SOME LONICERA SP. VARIETIES AFTER FIRST YEARS GROW IN ROMANIA. |